Visby’s POC COVID-19 Test Receives the US FDA’s EUA for Use in CLIA Waived Settings

 Visby’s POC COVID-19 Test Receives the US FDA’s EUA for Use in CLIA Waived Settings

Visby’s POC COVID-19 Test Receives the US FDA’s EUA for Use in CLIA Waived Settings

Shots:

  • The US FDA has granted EUA for rapid PCR COVID-19 test use at the POC and authorized for use in CLIA waived settings
  • Visby device is easy to use with the potential capability of running pooled tests in the future. The test is contained on a small, palm-sized device that plugs into a power outlet and is designed to deliver results within 30mins.
  • Visby Medical’s test is able to provide fast, accurate and actionable results at the point of need. The company will continue to work to expand authorized use cases to help provide a sense of security to critical areas and allow people to return to work safely

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: PRNewswire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post